Brivaracetam is widely utilized in preclinical and clinical research settings, primarily for its role as a high-affinity ligand to synaptic vesicle protein 2A (SV2A). It serves as a tool compound in exploring the molecular mechanisms of epilepsy, neuropsychiatric disorders, and neural transmission modulation. Its pharmacological specificity, combined with favorable pharmacokinetics, has made it a preferred choice over similar compounds for in vitro and in vivo models.

• SV2A Binding Studies
  Brivaracetam exhibits a high binding affinity for SV2A, a synaptic vesicle glycoprotein associated with neurotransmitter release. This makes it a critical compound in the development of novel antiepileptic therapies.

• Seizure Threshold Research
  It is frequently used in animal models to study seizure suppression and prevention. Its ability to modulate neuronal excitability makes it essential in evaluating anticonvulsant efficacy.

• Behavioral and Cognitive Impairment Models
  Brivaracetam is explored for its impact on memory formation, spatial cognition, and behavior—especially under seizure-inducing or stress conditions.

• Neuroprotective Mechanisms
  Research also focuses on Brivaracetam’s capacity to reduce neuronal damage following ischemic events or chronic excitotoxicity, suggesting potential beyond epilepsy.

• Drug Development and Optimization
  Its pharmacodynamic and pharmacokinetic profile provides a benchmark for next-generation SV2A ligands. Brivaracetam is often used in comparative studies alongside analogs like Levetiracetam.

Brivaracetam is generally legal to acquire for laboratory use, especially when the intent is clearly stated for non-human, scientific research. In most jurisdictions, it is not scheduled as a controlled substance, which makes its purchase and handling much more accessible to academic, clinical, and commercial researchers.

• Unscheduled in Many Countries
  Brivaracetam is not listed as a controlled substance in regions like the United States, the European Union, and Australia. However, researchers are advised to verify its status under their specific local laws.

• Intended for Laboratory Use Only
  Even when legally accessible, Brivaracetam must be used strictly for in vitro or animal-based research and not for any form of human or veterinary administration.

• No Prescription Required
  Because it is classified for research-only use, institutions and individuals purchasing it do not require a medical prescription or practitioner authorization.

• Responsibility of the Buyer
  Compliance with importation and handling laws rests with the buyer. Ensuring that all regulatory guidelines are followed helps avoid legal issues or customs delays.

• Safe Transaction Policies
  At RC Plug, we provide all necessary documentation and handle shipments with care to comply with cross-border chemical shipping regulations.

Brivaracetam functions as a selective ligand of the synaptic vesicle protein 2A (SV2A), which is integral to synaptic vesicle cycling and neurotransmitter release in the central nervous system. This mechanism underpins its ability to modulate neural excitability and reduce seizure susceptibility in experimental models.

• SV2A Modulation
  Brivaracetam binds to SV2A with significantly higher affinity than its predecessor, Levetiracetam. This interaction is believed to regulate synaptic vesicle exocytosis and inhibit hyper-synchronous neuronal firing.

• No GABAergic or Glutamatergic Receptor Activity
  Unlike other antiepileptic agents, Brivaracetam does not significantly interact with GABA-A, NMDA, or AMPA receptors, making its mechanism highly targeted and reducing off-target effects.

• Indirect Inhibition of Seizure Propagation
  By stabilizing presynaptic transmission through SV2A, Brivaracetam may reduce the likelihood of seizure propagation across neural circuits.

• Neuronal Homeostasis Maintenance
  Its regulatory effect on vesicle release contributes to the preservation of neural balance, which is critical during conditions of overstimulation or excitotoxic stress.

Though both Brivaracetam and Levetiracetam bind to the same synaptic target, SV2A, there are key pharmacodynamic and pharmacokinetic differences that distinguish them in laboratory applications. Brivaracetam was specifically developed as a next-generation analog with higher binding affinity and fewer behavioral side effects in animal studies.

• Binding Affinity
  Brivaracetam has a 10 to 30-fold greater affinity for SV2A compared to Levetiracetam. This allows for effective results at lower dosages in experimental settings.

• Blood-Brain Barrier Penetration
  Brivaracetam is more lipophilic, which improves its ability to cross the blood-brain barrier rapidly, making it preferable for rapid-onset models.

• Side Effect Profile
  Rodent studies suggest that Brivaracetam causes fewer adverse behavioral effects (e.g., agitation or sedation) than Levetiracetam, making it better tolerated in sensitive models.

• Dosing Efficiency
  Due to its potency, lower quantities of Brivaracetam may achieve equivalent or superior results compared to Levetiracetam in seizure threshold studies.

• Pharmacokinetics
  Brivaracetam shows faster onset and more predictable plasma concentrations in controlled animal testing, enhancing reproducibility.

Yes, Brivaracetam is increasingly being investigated in neuroprotective contexts due to its ability to stabilize neuronal firing and mitigate excitotoxicity. Its SV2A binding profile suggests a broader potential beyond just antiepileptic models, particularly in protecting neural tissues under stress conditions.

• Ischemia and Stroke Models
  Brivaracetam is used in rodent models to observe its effect on limiting cellular damage following ischemic brain injury, often caused by reduced blood flow or oxygen deprivation.

• Excitotoxicity Prevention
  Through its regulation of neurotransmitter release, Brivaracetam can help reduce the excessive glutamate-induced activation that damages neurons in pathological conditions.

• Neuroinflammation Mitigation
  Preliminary studies indicate that SV2A modulation may have downstream effects on neuroinflammatory pathways, making Brivaracetam relevant in neuroimmune research.

• Neurodegenerative Disease Research
  It is also explored in Alzheimer’s and Parkinson’s models to study how synaptic regulation might slow neurodegeneration or enhance synaptic resilience.

• Post-Seizure Brain Recovery
  Brivaracetam’s ability to reduce secondary injury following seizure episodes makes it a candidate for studies on long-term brain preservation and rehabilitation.

At RC Plug, we are committed to supplying only laboratory-grade compounds, and our Brivaracetam consistently meets or exceeds ≥99% purity standards. This level of purity is essential for obtaining reliable, reproducible data in pharmacological, biochemical, and analytical research environments.

• High-Performance Liquid Chromatography (HPLC) Verified
  Every batch of Brivaracetam undergoes HPLC analysis to ensure its chemical composition meets our ≥99% purity requirement. This method allows for accurate detection of trace impurities or degradation products.

• Certificate of Analysis (COA) Available
  We provide a COA with each batch, detailing the analytical methodology and test results, including assay purity, moisture content, and residual solvents.

• No Additives or Binders
  Our Brivaracetam is unadulterated, free from binders, fillers, or other excipients, ensuring precise dosing and controlled experimental conditions.

• Batch-Specific Testing
  Each production batch is individually tested and traceable. This ensures quality consistency and compliance with research standards across different orders.

• Stability-Checked
  Purity is maintained across the product’s shelf life when stored as directed, making it suitable for long-term projects and repeated assay protocols.

Proper storage of Brivaracetam is crucial to maintain its chemical integrity and prevent degradation. This compound, like many sensitive research chemicals, requires specific environmental conditions to ensure long-term usability and reproducibility in experiments.

• Refrigerated Storage (2–8°C)
  Brivaracetam should be stored in a refrigerator within the 2–8°C range. This temperature window helps slow down any potential breakdown processes, especially for longer storage periods.

• Dry Environment
  Avoid storing the product in humid or damp areas. Exposure to moisture can affect the crystalline structure and potentially introduce chemical instability.

• Airtight Container Required
  Always keep the compound sealed in its original container or a validated airtight vessel. This reduces oxidation risk and prevents contamination from external particles.

• Protect from Light
  Store the vial or pouch in a dark place or inside an opaque container, as light exposure can lead to photo-degradation, particularly under UV wavelengths.

• Avoid Frequent Temperature Fluctuations
  Repeatedly moving the product in and out of refrigeration may lead to condensation and thermal stress, both of which may compromise stability.

• Do Not Freeze
  Freezing is not recommended unless specifically reconstituted for such storage. Freeze-thaw cycles can cause chemical precipitation or aggregation.

Brivaracetam is not significantly soluble in water, which makes it essential to use appropriate solvents when preparing research solutions. Understanding its solubility profile ensures better dosing precision and compound activity in vitro and in vivo models.

• Poor Water Solubility
  Brivaracetam has very low solubility in aqueous solutions, limiting its use in water-based delivery systems or buffer-only mediums without modification.

• Soluble in Organic Solvents
  It dissolves effectively in solvents like dimethyl sulfoxide (DMSO), ethanol, and methanol, which are commonly used in pharmacological testing environments.

• Solubility Concentration Range
  Solubility in DMSO or ethanol typically exceeds 20 mg/mL, which is suitable for preparing concentrated stock solutions.

• Avoid Aqueous Buffers Alone
  Using phosphate-buffered saline (PBS) or distilled water without co-solvents may lead to precipitation or poor dispersion in assays.

• Filtered Before Use
  For cell culture or in vivo applications, solutions should be sterile-filtered through a 0.22 µm membrane to eliminate particulates and ensure compatibility.

Brivaracetam is delivered in its pure, unadulterated form, appearing as a white to off-white crystalline powder. Its physical attributes not only reflect its purity but also assist in identification and proper handling in research environments.

• Color and Form
  Brivaracetam typically appears as a white or slightly off-white powder. Any significant discoloration could suggest degradation or contamination.

• Crystalline Consistency
  The compound’s crystalline structure ensures stability and supports consistent weighing for dose preparation. It is also suitable for analytical techniques like X-ray diffraction and FTIR.

• Odorless and Tasteless
  There is no detectable odor or taste, which confirms its lack of volatile impurities or degradation byproducts.

• Non-Hygroscopic
  Brivaracetam generally resists absorbing moisture from the air, which enhances its shelf life when stored correctly.

• Stable Under Recommended Conditions
  When kept in a sealed, cool, and dark environment, the compound maintains structural integrity over extended periods.

At RC Plug, we understand that researchers have different needs based on the scope and duration of their studies. That’s why we offer Brivaracetam in multiple packaging sizes to accommodate both small-batch testing and larger, longitudinal research projects.

• 500mg Pack
  Ideal for pilot studies, initial assays, or dose-response testing where small quantities are required to establish protocols.

• 1g Pack
  Suited for mid-size research operations, especially those conducting in vitro assays, cytotoxicity screenings, or multiple replicates.

• 5g Pack
  Designed for more extensive testing including animal model studies, pharmacokinetic evaluations, or formulation development.

• 10g Pack
  Best for institutions and commercial R&D labs conducting broad-scale or long-term studies, including chronic administration experiments.

• Bulk and Custom Orders
  For larger quantities, we accommodate custom sourcing with advanced notice. All bulk orders are shipped with full documentation and additional verification steps upon request.

• Consistent Packaging Materials
  All quantities are packed in tamper-evident, airtight containers with clear labeling for safety, compliance, and traceability.

The delivery time for your Brivaracetam order depends on your location, selected shipping method, and payment confirmation time. At RC Plug, we prioritize fast order fulfillment, with most packages dispatched within 24 hours after payment clearance. Our global logistics partners allow us to offer express shipping options and dependable tracking services.

• 24-Hour Dispatch
  Orders confirmed and paid for before our daily cutoff time are packed and shipped within 24 hours. Orders placed over weekends or holidays ship on the next business day.

• Overnight Shipping Available
  For customers in eligible locations (such as the U.S., EU, and parts of Asia), overnight shipping ensures your package arrives within 1 business day after dispatch.

• Standard Shipping Timeline
  Typical delivery times range from 2 to 5 business days for most destinations, depending on regional courier efficiency and customs processing.

• Real-Time Tracking Provided
  Every order includes a tracking number that allows you to monitor the shipment’s status from dispatch to delivery. Updates are provided via email.

• Priority Handling for Large Orders
  Bulk or urgent orders may qualify for expedited processing and upgraded shipping services. Contact support if you have time-sensitive requirements.

• No Delays for Documentation
  Because no prescription is needed, there’s no paperwork or approval process to slow your order down.

We understand how critical timing and reliability are for research operations. If your Brivaracetam shipment is lost, delayed beyond a reasonable timeframe, or arrives damaged, RC Plug takes full responsibility for making it right. Our 30-day guarantee ensures that you’re covered.

• Full Replacement Guarantee
  If your package is lost in transit, we will reship your order at no additional cost after verifying with the courier and confirming the tracking failure.

• Refund Option Available
  You may opt for a full refund instead of a replacement, especially in cases where delivery timelines are no longer compatible with your research needs.

• Tracking Investigation Support
  Our customer support team liaises directly with shipping providers to initiate trace investigations and push for updates when delays occur.

• Fast Resolution Process
  Claims regarding lost or delayed packages are resolved promptly, typically within 3–5 business days after notification.

• Discreet Reshipment Protocol
  All replacements are shipped using the same high-level discreet packaging to ensure your privacy is preserved a second time.

Yes, Brivaracetam can interact with other compounds in research studies, particularly those affecting neurotransmitter systems or ion channel modulation. Understanding potential interactions is important when designing multi-compound assays or co-administration studies in animal models.

• Interaction with SV2A Ligands
  Brivaracetam may show additive or synergistic effects when combined with other SV2A-binding compounds such as Levetiracetam. These interactions can influence neurotransmitter release patterns.

• Minimal Cytochrome P450 Activity
  In contrast to many CNS-active drugs, Brivaracetam has limited interaction with major CYP450 enzymes, reducing metabolic interference in liver microsome studies.

• Caution with Sodium Channel Blockers
  Although Brivaracetam does not act directly on sodium channels, its downstream effects can be enhanced or altered in the presence of sodium channel inhibitors.

• No Direct GABAergic Modulation
  It does not significantly interact with GABA-A or GABA-B receptors, making it useful in combination studies with compounds that do modulate those pathways.

• Combination with Excitatory Modulators
  In studies involving glutamate or NMDA agonists, Brivaracetam’s stabilizing effect may attenuate overexcitation, which is useful for balancing excitotoxicity models.

Though Brivaracetam shares structural features with racetams, it does not belong to the classical racetam nootropic family in terms of mechanism or intended research application. Its targeted SV2A binding and antiepileptic potential distinguish it from cognitive-enhancing racetams like Piracetam or Aniracetam.

• SV2A Focus vs. AMPA/Cholinergic Activity
  While racetams typically act on glutamate and acetylcholine receptors to enhance cognition, Brivaracetam binds SV2A to modulate synaptic transmission and prevent seizures.

• Nootropic vs. Antiepileptic Use
  Classical racetams are studied for memory, focus, and learning enhancement. Brivaracetam, on the other hand, is primarily researched for seizure control and neural stabilization.

• Higher Binding Specificity
  Brivaracetam shows greater receptor selectivity than many racetams, reducing the risk of off-target effects in delicate experimental systems.

• Behavioral Profiles Differ
  In animal models, Brivaracetam exhibits anticonvulsant behavior with minimal cognitive enhancement, while racetams are often neutral in seizure models.

• Molecular Structure Variations
  Despite sharing the -racetam suffix, Brivaracetam’s core structure diverges significantly in terms of side chains and receptor binding pockets.

Yes, RC Plug offers a flexible 30-day return and replacement policy to ensure your satisfaction. If you encounter issues related to product quality, shipping damage, or incorrect fulfillment, you may initiate a return request within this window. We make the process hassle-free for verified customers.

• Returns Accepted Within 30 Days
  You may return unopened and unused Brivaracetam within 30 days from the date of delivery for a full refund or exchange.

• Eligible Return Conditions
  Returns are accepted in cases of product mismatch, shipment damage, or if the item does not meet the description or quality standards outlined on the product page.

• Tamper-Evident Packaging Requirement
  Returned items must still have their original tamper-evident seals intact. Opened containers are not eligible unless the product was defective.

• Quick Refund Processing
  Refunds are typically processed within 5–7 business days after we receive and inspect the returned item.

• Return Shipping Support
  In cases where the error is on our side (e.g., wrong item shipped or damaged goods), we cover the cost of return shipping and reshipment.

• Customer Assistance Provided
  Our support team is available to guide you through every step of the return process, ensuring it’s fast and seamless.

Yes, all Brivaracetam sold through RC Plug is thoroughly tested for contaminants to ensure its safety and suitability for scientific research. We understand that impurities can significantly compromise experimental results, so each batch undergoes comprehensive analysis before being approved for distribution.

• HPLC and GC-MS Testing
  We use High-Performance Liquid Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS) to detect and quantify any chemical impurities or unknown substances.

• Heavy Metal Screening
  All Brivaracetam batches are screened for heavy metals such as arsenic, lead, cadmium, and mercury using industry-standard detection methods.

• Microbial Testing
  Though not biologically active or consumable, we test for microbial contaminants in select batches to ensure laboratory sterility, particularly when used in cell culture studies.

• Solvent Residue Analysis
  Residual solvents from the synthesis or purification process are identified and kept well below ICH (International Council for Harmonisation) guidelines.

• Batch-Level Documentation
  Each container is linked to a Certificate of Analysis (COA) that includes full contaminant screening results, making regulatory compliance and audit readiness simple for researchers.